NCT01850680 Single Ascending Dose Study of Safety and Tolerability of Sarilumab and Methotrexate in Japanese Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE1
NCT01838083 Euglycemic Clamp Study Comparing Two New Insulin Glargine Formulations in Subjects With Type 1 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT01825382 Role of Mobile Technology to Improve Diabetes Care in Adults With Type 1 Diabetes: the REMOTE-T1D Study, a Pilot Study Status COMPLETED Phase PHASE4
NCT01812707 Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) in Patients With Primary Hypercholesterolemia on Stable Atorvastatin Therapy in Japan Status COMPLETED Phase PHASE2
NCT01810848 Pilot Study of Therapy With Hylan G-F 20 Exercise Capacity Status TERMINATED Phase PHASE1
NCT01809015 Evaluation of Oral Anticoagulation With Vitamin K Antagonists - The thrombEVAL Study Programme Status COMPLETED Phase N/A
NCT01803945 A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease Status TERMINATED Phase PHASE1
NCT01802684 OPTIMOX-aflibercept as First-line Therapy in Patients With Unresectable Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT01798706 Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients Status COMPLETED Phase PHASE3
NCT01795183 Effectiveness and Safety of Amisulpride in Chinese Patients With Schizophrenia Status COMPLETED Phase PHASE4
NCT01793103 Brigham and Women's Rheumatoid Arthritis Sequential Study Status ACTIVE_NOT_RECRUITING Phase N/A
NCT01785329 Pharmacokinetic of Alirocumab SAR236553 (REGN727) Administered Subcutaneously at 3 Different Injection Sites in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01768572 To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN) Status COMPLETED Phase PHASE3
NCT01768559 Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic Patients Status COMPLETED Phase PHASE3
NCT01767714 Evaluation of Plerixafor Plus G-CSF to Mobilize and Collect 5×10^6CD34+ Cells/kg in Non-Hodgkin's Lymphoma (NHL) Patients for Autologous Transplantation Status COMPLETED Phase PHASE3
NCT01764997 An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate Status TERMINATED Phase PHASE3
NCT01757171 Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma Status COMPLETED Phase PHASE2